Article

ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19

2020-03-27

Abstract excerpt

The pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- CoV-2) has resulted in several thousand deaths worldwide in just a few months. Patients who died from Coronavirus disease 2019 (COVID-19) often had comorbidities, such as hypertension, diabetes, and chronic obstructive lung disease. The angiotensin-converting enzyme 2 (ACE2) was identified as a crucial factor that facilitates SARS-Co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bb27f71f-bc94-5454-a416-5be943171b0f
DOI: 10.1101/2020.03.21.20040261

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19DOI 10.1101/2020.03.21.20040261Read

ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19Semantic proximity Read

Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses.Semantic proximity Read

A computational and bioinformatic analysis of ACE2: an elucidation of its dual role in COVID-19 pathology and finding its associated partners as potential therapeutic targetsSemantic proximity Read

ACE2 and COVID-19 Susceptibility and SeveritySemantic proximity Read

A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible TargetsSemantic proximity Read

ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID‐19Semantic proximity Read

Epigenetic mechanisms and host factors impact ACE2 gene expression: Implications in COVID-19 susceptibilitySemantic proximity Read

ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk FactorsSemantic proximity Read

Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2Semantic proximity Read

Systematic identification of ACE2 expression modulators reveals cardiomyopathy as a risk factor for mortality in COVID-19 patientsSemantic proximity Read

SARS-CoV-2, ACE2 expression, and systemic organ invasionSemantic proximity Read

ACE2 interaction networks in COVID-19: a physiological framework for prediction of outcome in patients with cardiovascular risk factorsSemantic proximity Read